Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid...
28 KB (2,480 words) - 10:45, 23 September 2024
Anti-amyloid drugs (section Lecanemab)
reasons. Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an...
8 KB (2,404 words) - 12:33, 27 September 2024
ransomware attack, causing a shutdown of some of its logistical systems. Lecanemab, branded as "Leqembi" was approved by the U.S. Food and Drug Administration...
12 KB (891 words) - 10:01, 2 July 2024
Monoclonal antibody therapy (section Lecanemab)
for Alzheimer's disease, Aducanemab and Lecanemab. Aducanemab has received accelerated approval while Lecanemab has received full approval. Several clinical...
59 KB (4,170 words) - 07:03, 20 October 2024
beta with immunotherapy medications such as donanemab, aducanumab, and lecanemab. Aducanumab was approved by the US Food and Drug Administration (FDA)...
186 KB (19,741 words) - 21:12, 1 November 2024
National Institute for Health and Care Excellence (NICE) confirms that Lecanemab, the first drug developed that slows the early stages of Alzheimer's disease...
408 KB (45,609 words) - 18:11, 3 November 2024
folium N06DX01 Memantine N06DX02 Ginkgo folium N06DX03 Aducanumab N06DX04 Lecanemab N06DX05 Donanemab N06DX30 Combinations "ATC (Anatomical Therapeutic Chemical...
4 KB (441 words) - 21:47, 27 June 2024
Year Approved (US) Year Approved (EU) Additional Information LEQEMBI™ [(lecanemab-irmb)] Indicated for patients with mild cognitive impairment or mild dementia...
48 KB (3,837 words) - 18:51, 12 September 2024
clinical trials included aducanumab, bapineuzumab, crenezumab, gantenerumab, lecanemab, and solanezumab. Imaging compounds, notably Pittsburgh compound B, (6-OH-BTA-1...
44 KB (4,830 words) - 18:56, 11 August 2024
ebolavirus glycoprotein Ebola virus Lebrikizumab mab humanized IL-13 asthma Lecanemab Leqembi mab humanized β-amyloid Y Alzheimer's disease Lemalesomab mab...
137 KB (4,083 words) - 21:25, 19 October 2024